0001203311-18-000037.txt : 20180522
0001203311-18-000037.hdr.sgml : 20180522
20180522201014
ACCESSION NUMBER: 0001203311-18-000037
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180518
FILED AS OF DATE: 20180522
DATE AS OF CHANGE: 20180522
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Simonian Nancy A
CENTRAL INDEX KEY: 0001359574
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-32405
FILM NUMBER: 18853784
MAIL ADDRESS:
STREET 1: C/O SYROS PHARMACEUTICALS, INC.
STREET 2: 620 MEMORIAL DRIVE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SEATTLE GENETICS INC /WA
CENTRAL INDEX KEY: 0001060736
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 911874389
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 21823 30TH DRIVE SE
STREET 2: SUITE
CITY: BOTHELL
STATE: WA
ZIP: 98021
BUSINESS PHONE: 4255274000
MAIL ADDRESS:
STREET 1: 21823 30TH DRIVE SE
STREET 2: SUITE
CITY: BOTHELL
STATE: WA
ZIP: 98021
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2018-05-18
0
0001060736
SEATTLE GENETICS INC /WA
SGEN
0001359574
Simonian Nancy A
21823 30TH DRIVE SE
BOTHELL
WA
98021
1
0
0
0
Common Stock
2018-05-18
4
A
0
3700
0.0
A
21800
D
Non-Qualified Stock Option (right to buy)
56.77
2018-05-18
4
A
0
9260
0.0
A
2028-05-18
Common Stock
9260
9260
D
These shares represent restricted stock units and will be settled in common stock upon vesting.
Restricted stock units shall vest in full on May 18, 2019.
The option shall vest in full on May 18, 2019.
/s/ Jean Liu
2018-05-22